Free Trial

Avantor (AVTR) Stock Forecast & Price Target

$23.73
-0.41 (-1.70%)
(As of 01:51 PM ET)

Avantor - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 16 Analyst Ratings

Consensus Price Target

$26.71
12.58% Upside
High Forecast$30.00
Average Forecast$26.71
Low Forecast$22.00
TypeCurrent Forecast
5/29/23 to 5/28/24
1 Month Ago
4/29/23 to 4/28/24
3 Months Ago
2/28/23 to 2/28/24
1 Year Ago
5/29/22 to 5/29/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
12 Buy rating(s)
12 Buy rating(s)
8 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$26.71$26.71$26.14$28.75
Forecasted Upside12.58% Upside16.37% Upside16.90% Upside32.39% Upside
Get Avantor Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AVTR and its competitors with MarketBeat's FREE daily newsletter.

AVTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AVTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Avantor Stock vs. The Competition

TypeAvantorMedical CompaniesS&P 500
Consensus Rating Score
2.75
2.70
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside11.03% Upside807.26% Upside9.86% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/29/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$27.00 ➝ $26.00+8.60%
4/18/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$23.00 ➝ $25.00+2.54%
4/10/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$27.00 ➝ $30.00+17.79%
4/4/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$26.00 ➝ $28.00+9.16%
2/15/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$25.00 ➝ $29.00+18.13%
2/15/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$24.00 ➝ $30.00+21.70%
2/15/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$26.00 ➝ $29.00+18.08%
2/15/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$28.00 ➝ $29.00+18.08%
1/26/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$22.50 ➝ $26.00+18.51%
12/13/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoveragePeer Perform
12/11/2023TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$21.00 ➝ $28.00+33.46%
12/7/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$23.00 ➝ $26.00+23.99%
10/30/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$24.00 ➝ $22.00+29.03%
9/28/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$22.00+5.90%
7/31/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Larew
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
7/30/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$27.00 ➝ $24.00+12.78%
5/1/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
2/8/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$25.00 ➝ $28.00+17.60%
11/1/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$26.00+30.13%
10/31/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$32.00 ➝ $25.00+30.07%
9/19/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$35.00 ➝ $28.00+24.56%
9/15/2022KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$51.00 ➝ $40.00+70.50%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 02:08 PM ET.

AVTR Frequently Asked Questions

What is Avantor's stock forecast and purchase recommendation?

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Avantor is $26.71, with a high forecast of $30.00 and a low forecast of $22.00. The consensus rating for Avantor stock is Moderate Buy based on the current 4 hold ratings and 12 buy ratings for AVTR. Learn more on AVTR's analyst rating history.

Do Wall Street analysts like Avantor more than its competitors?

Analysts like Avantor more than other "medical" companies. The consensus rating score for Avantor is 2.75 while the average consensus rating score for "medical" companies is 2.70. Learn more on how AVTR compares to other companies.

Does Avantor's stock price have much upside?

According to analysts, Avantor's stock has a predicted upside of 16.60% based on their 12-month stock forecasts.

What analysts cover Avantor?

Avantor has been rated by research analysts at Barclays, Deutsche Bank Aktiengesellschaft, Evercore ISI, and Robert W. Baird in the past 90 days.


Stock Forecasts and Research Tools

This page (NYSE:AVTR) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners